US Stock MarketDetailed Quotes

ELYM Eliem Therapeutics

Watchlist
  • 8.500
  • +0.210+2.53%
Close Jun 12 16:00 ET
  • 8.680
  • +0.180+2.12%
Post 16:42 ET
252.89MMarket Cap-16346P/E (TTM)

Eliem Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
88.01%-1.82M
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
-64.67%-13.97M
Net income from continuing operations
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
-67.40%-14.6M
Operating gains losses
112.12%28K
-174.51%-304K
118.21%330K
-100.40%-4K
-137.96%-399K
-230.51%-231K
266.53%408K
---1.81M
1,355.70%992K
1,336.47%1.05M
Other non cash items
-27.87%88K
-8.58%405K
-23.68%87K
-23.21%86K
0.92%110K
12.96%122K
-96.22%443K
--114K
--112K
--109K
Change In working capital
73.96%-640K
1,692.38%3.76M
393.60%1.42M
177.81%7.47M
-11.24%-2.67M
-705.42%-2.46M
105.03%210K
-139.67%-484K
158.58%2.69M
-230.40%-2.4M
-Change in prepaid assets
764.00%216K
679.89%7.37M
663.50%1.54M
1,648.01%6.61M
-3.19%-809K
-98.97%25K
109.21%945K
-132.50%-274K
94.15%-427K
76.45%-784K
-Change in payables and accrued expense
46.10%-725K
-1,346.93%-3.3M
98.47%-2K
49.24%-633K
-278.97%-1.32M
-425.67%-1.35M
-106.48%-228K
-129.77%-131K
-905.65%-1.25M
-55.20%737K
-Change in other current assets
101.34%15K
291.67%115K
-91.67%1K
-63.42%1.64M
81.52%-409K
52.34%-1.12M
-102.34%-60K
117.14%12K
58.90%4.49M
-331.24%-2.21M
-Change in other current liabilities
-668.42%-146K
5.59%-422K
-34.07%-122K
-16.80%-146K
4.93%-135K
78.65%-19K
-6,485.71%-447K
-1,400.00%-91K
---125K
---142K
Cash from discontinued investing activities
Operating cash flow
88.01%-1.82M
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
-64.67%-13.97M
Investing cash flow
Cash flow from continuing investing activities
137.21%13.75M
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
15.69M
Net investment purchase and sale
137.21%13.75M
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
--15.69M
Cash from discontinued investing activities
Investing cash flow
137.21%13.75M
100.29%68.98M
157.37%36.75M
229.50%28.04M
-110.21%-1.6M
243.67%5.8M
129.96%34.44M
277.34%14.28M
107.96%8.51M
--15.69M
Financing cash flow
Cash flow from continuing financing activities
1,400.00%15K
841K
288K
528K
24K
1K
0
0
0
0
Proceeds from stock option exercised by employees
1,400.00%15K
--841K
--288K
--528K
--24K
--1K
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
1,400.00%15K
--841K
--288K
--528K
--24K
--1K
--0
--0
--0
--0
Net cash flow
Beginning cash position
113.63%93.11M
-7.11%43.59M
59.56%57.35M
-22.42%25.29M
7.85%34.44M
-7.11%43.59M
129.03%46.92M
-42.78%35.94M
-67.23%32.6M
-33.35%31.93M
Current changes in cash
227.38%11.95M
1,780.54%49.22M
519.13%36.09M
639.62%32.06M
-654.12%-9.54M
36.69%-9.38M
-111.18%-2.93M
136.67%5.83M
111.80%4.33M
-96.66%1.72M
Effect of exchange rate changes
-112.12%-28K
174.51%304K
-118.21%-330K
100.40%4K
137.96%399K
230.51%231K
-266.53%-408K
--1.81M
-1,355.70%-992K
-1,336.47%-1.05M
End cash Position
204.99%105.03M
113.63%93.11M
113.63%93.11M
59.56%57.35M
-22.42%25.29M
7.85%34.44M
-7.11%43.59M
-7.11%43.59M
-42.78%35.94M
-67.23%32.6M
Free cash flow
88.01%-1.82M
44.88%-20.6M
88.79%-947K
183.59%3.49M
42.97%-7.97M
-40.80%-15.18M
-3.60%-37.37M
-7.17%-8.45M
67.80%-4.18M
-64.67%-13.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 88.01%-1.82M44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M-64.67%-13.97M
Net income from continuing operations 92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M-67.40%-14.6M
Operating gains losses 112.12%28K-174.51%-304K118.21%330K-100.40%-4K-137.96%-399K-230.51%-231K266.53%408K---1.81M1,355.70%992K1,336.47%1.05M
Other non cash items -27.87%88K-8.58%405K-23.68%87K-23.21%86K0.92%110K12.96%122K-96.22%443K--114K--112K--109K
Change In working capital 73.96%-640K1,692.38%3.76M393.60%1.42M177.81%7.47M-11.24%-2.67M-705.42%-2.46M105.03%210K-139.67%-484K158.58%2.69M-230.40%-2.4M
-Change in prepaid assets 764.00%216K679.89%7.37M663.50%1.54M1,648.01%6.61M-3.19%-809K-98.97%25K109.21%945K-132.50%-274K94.15%-427K76.45%-784K
-Change in payables and accrued expense 46.10%-725K-1,346.93%-3.3M98.47%-2K49.24%-633K-278.97%-1.32M-425.67%-1.35M-106.48%-228K-129.77%-131K-905.65%-1.25M-55.20%737K
-Change in other current assets 101.34%15K291.67%115K-91.67%1K-63.42%1.64M81.52%-409K52.34%-1.12M-102.34%-60K117.14%12K58.90%4.49M-331.24%-2.21M
-Change in other current liabilities -668.42%-146K5.59%-422K-34.07%-122K-16.80%-146K4.93%-135K78.65%-19K-6,485.71%-447K-1,400.00%-91K---125K---142K
Cash from discontinued investing activities
Operating cash flow 88.01%-1.82M44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M-64.67%-13.97M
Investing cash flow
Cash flow from continuing investing activities 137.21%13.75M100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M15.69M
Net investment purchase and sale 137.21%13.75M100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M--15.69M
Cash from discontinued investing activities
Investing cash flow 137.21%13.75M100.29%68.98M157.37%36.75M229.50%28.04M-110.21%-1.6M243.67%5.8M129.96%34.44M277.34%14.28M107.96%8.51M--15.69M
Financing cash flow
Cash flow from continuing financing activities 1,400.00%15K841K288K528K24K1K0000
Proceeds from stock option exercised by employees 1,400.00%15K--841K--288K--528K--24K--1K--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 1,400.00%15K--841K--288K--528K--24K--1K--0--0--0--0
Net cash flow
Beginning cash position 113.63%93.11M-7.11%43.59M59.56%57.35M-22.42%25.29M7.85%34.44M-7.11%43.59M129.03%46.92M-42.78%35.94M-67.23%32.6M-33.35%31.93M
Current changes in cash 227.38%11.95M1,780.54%49.22M519.13%36.09M639.62%32.06M-654.12%-9.54M36.69%-9.38M-111.18%-2.93M136.67%5.83M111.80%4.33M-96.66%1.72M
Effect of exchange rate changes -112.12%-28K174.51%304K-118.21%-330K100.40%4K137.96%399K230.51%231K-266.53%-408K--1.81M-1,355.70%-992K-1,336.47%-1.05M
End cash Position 204.99%105.03M113.63%93.11M113.63%93.11M59.56%57.35M-22.42%25.29M7.85%34.44M-7.11%43.59M-7.11%43.59M-42.78%35.94M-67.23%32.6M
Free cash flow 88.01%-1.82M44.88%-20.6M88.79%-947K183.59%3.49M42.97%-7.97M-40.80%-15.18M-3.60%-37.37M-7.17%-8.45M67.80%-4.18M-64.67%-13.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg